ESR1 and triple-negative breast carcinoma: The anticancer activity of the three mono fluoro derivatives was reported by Santos et al. [39] against estrogen-receptor-positive breast cancer cells MCF-7 and the triple-negative breast cancer (TNBC) cells MDA-MB-231.